These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 10966531

  • 21. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S, Kitakaze M.
    Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
    [Abstract] [Full Text] [Related]

  • 22. A hard look at angiotensin receptor blockers in heart failure.
    Gring CN, Francis GS.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1841-6. PubMed ID: 15519017
    [Abstract] [Full Text] [Related]

  • 23. Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
    Cohn JN.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun 02; 1(2 Suppl):S38-40. PubMed ID: 17199220
    [Abstract] [Full Text] [Related]

  • 24. The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure.
    Hebert PR, Foody JM, Hennekens CH.
    Curr Vasc Pharmacol; 2003 Mar 02; 1(1):33-9. PubMed ID: 15320851
    [Abstract] [Full Text] [Related]

  • 25. Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
    Scow DT, Smith EG, Shaughnessy AF.
    Am Fam Physician; 2003 Nov 01; 68(9):1795-8. PubMed ID: 14620599
    [Abstract] [Full Text] [Related]

  • 26. Clinical studies on the therapy of heart failure using ACE-inhibitors and AT1-receptor blockers--does combination treatment make sense?
    Hennig L.
    Clin Nephrol; 2002 Jul 01; 58 Suppl 1():S7-11. PubMed ID: 12227730
    [Abstract] [Full Text] [Related]

  • 27. Angiotensin II receptor blockers in chronic heart failure--not as ELITE as expected!
    Farquharson CA, Struthers AD.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar 01; 1(1):21-2. PubMed ID: 11967790
    [Abstract] [Full Text] [Related]

  • 28. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M, Franchini M, Fanos V.
    Pharmacotherapy; 2008 Jan 01; 28(1):125-30. PubMed ID: 18154482
    [Abstract] [Full Text] [Related]

  • 29. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
    Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP.
    Int J Cardiol; 2004 Feb 01; 93(2-3):105-11. PubMed ID: 14975535
    [Abstract] [Full Text] [Related]

  • 30. [Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists. Pharmacologic features].
    Vaz-da-Silva M.
    Rev Port Cardiol; 2000 Dec 01; 19 Suppl 2():II19-32. PubMed ID: 11301908
    [Abstract] [Full Text] [Related]

  • 31. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM, Böhm M.
    Ther Adv Cardiovasc Dis; 2008 Jun 01; 2(3):167-77. PubMed ID: 19124420
    [Abstract] [Full Text] [Related]

  • 32. Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Singh RK, Barker S.
    Curr Opin Investig Drugs; 2005 Mar 01; 6(3):269-74. PubMed ID: 15816503
    [Abstract] [Full Text] [Related]

  • 33. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Wade VL, Gleason BL.
    Ann Pharmacother; 2004 Mar 01; 38(7-8):1278-82. PubMed ID: 15187210
    [Abstract] [Full Text] [Related]

  • 34. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan 01; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE, McKinnie JJ, Greenberg SS, Giles TD.
    Prog Cardiovasc Dis; 1999 Jan 01; 41(4):265-300. PubMed ID: 10362349
    [Abstract] [Full Text] [Related]

  • 36. Renin Angiotensin Aldosterone System Blockade: Little to No Rationale for ACE Inhibitor and ARB Combinations.
    Holdiness A, Monahan K, Minor D, de Shazo RD.
    Am J Med; 2011 Jan 01; 124(1):15-9. PubMed ID: 21187182
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR, Nussberger J, Waeber B.
    J Hypertens Suppl; 1993 Apr 01; 11(3):S53-8. PubMed ID: 8315521
    [Abstract] [Full Text] [Related]

  • 38. Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure.
    Chang PI, Pitt B.
    Cardiologia; 1994 Dec 01; 39(12 Suppl 1):409-11. PubMed ID: 7634306
    [Abstract] [Full Text] [Related]

  • 39. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
    Probstfield JL, O'Brien KD.
    Am J Cardiol; 2010 Jan 04; 105(1 Suppl):10A-20A. PubMed ID: 20102969
    [Abstract] [Full Text] [Related]

  • 40. [Efficacy of angiotensin II receptor antagonists as a novel drug for the treatment of chronic heart failure--in comparison with ACE inhibitors].
    Kitakaze M, Kuzuya T, Hori M.
    Nihon Rinsho; 1999 May 04; 57(5):1148-57. PubMed ID: 10361449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.